MTS Health Partners Taps Salamon to Deepen Private Equity Ties

NEW YORK, NY – May 07, 2026 – MTS Health Partners, a premier investment bank focused exclusively on the healthcare industry, has made a significant strategic move by appointing Adam Salamon to a newly created role dedicated to driving relationships with financial sponsors. The hire signals a deliberate effort by the firm to double down on the private equity community, a critical engine of capital and deal flow in the rapidly evolving healthcare sector.

Mr. Salamon, who joins MTS from Citizens Financial Group's Healthcare Services practice, will be tasked with leading the expansion of the firm's strategic partnerships with private equity firms. This appointment is not merely a personnel change but a clear reflection of the intense competition and immense opportunity defining healthcare investment banking today. As private equity continues to pour capital into the sector, specialized advisory firms are recognizing that deep, dedicated relationships with sponsors are no longer a luxury but a core pillar of a successful growth strategy.

In a statement, Curtis S. Lane, Founding Partner of MTS Health Partners, underscored the strategic importance of the hire. "With his hire we are reinforcing the firm's continued investment in strengthening relationships with private equity sponsors and enhancing client service across its platform," Lane said. "Adam's extensive experience navigating the financial sponsor landscape combined with a deep understanding of the healthcare sector makes him the ideal leader to spearhead this effort."

The Strategic Imperative for Sponsor Focus

MTS's decision to create a dedicated sponsor coverage role comes as the healthcare private equity market is experiencing unprecedented activity. After a record-breaking 2025 that saw disclosed deal values exceed an estimated $191 billion, the appetite for healthcare assets remains robust. Private equity firms are flush with 'dry powder'—uninvested capital specifically earmarked for healthcare—and are actively seeking opportunities to deploy it in a sector known for its defensive characteristics and long-term growth drivers, such as an aging population and constant innovation.

This influx of capital has created a fiercely competitive environment for investment banks. The firms that can provide differentiated insights and seamless execution for private equity clients are best positioned to capture a larger share of the M&A advisory market. By appointing Salamon, MTS is betting that a high-touch, specialized approach is the key to unlocking further growth. His role will be to serve as a central point of contact for the private equity world, understanding their investment theses, anticipating their needs, and connecting them with opportunities across the healthcare landscape, from services and tech to pharmaceuticals.

This focus is critical as PE firms increasingly employ complex "buy-and-build" strategies, where they acquire a platform company and then make numerous smaller, strategic acquisitions to scale the business. This approach, prevalent in fragmented subsectors like dental care and health IT, requires an advisory partner with deep industry knowledge and an even deeper network of relationships, a role Salamon is now positioned to fill.

A Calculated Bet on Specialized Expertise

The hiring of Adam Salamon is also emblematic of a broader industry trend: the rising value of specialized expertise over generalist financial knowledge. In a sector as complex and regulated as healthcare, a deep understanding of subsector nuances, reimbursement models, and clinical data can be the difference between a successful transaction and a failed one. Salamon's background makes him a prime example of the type of talent that is now in high demand.

His tenure at Citizens Financial Group involved covering both healthcare companies and the financial sponsors that invest in them, giving him a valuable dual perspective. Prior roles advising clients across multiple healthcare subsectors have further honed his industry-specific acumen. This deep-seated knowledge is complemented by a formal business education, including an M.B.A from UNC Kenan-Flagler Business School.

For his part, Salamon expressed enthusiasm for joining a platform known for its singular focus. "MTS Health Partners has built an unmatched reputation as a leading independent voice in healthcare investment banking," he stated. "I am excited to join such a focused and entrepreneurial team. I look forward to leveraging the MTS platform to provide financial sponsors with the specialized attention required to execute complex transactions in today's evolving healthcare market."

This sentiment highlights the symbiotic relationship between specialized firms and specialized talent. As investment banks become more niche, they attract professionals who want to build a career dedicated to a specific industry, creating a virtuous cycle of deepening expertise that benefits both the firm and its clients.

Navigating a Complex and Scrutinized Market

While the opportunities in healthcare private equity are immense, the landscape is fraught with challenges that demand sophisticated navigation. Salamon steps into his role at a time of heightened regulatory scrutiny. Government bodies like the Federal Trade Commission (FTC) and the Department of Justice (DOJ) are taking a much closer look at private equity's role in healthcare, concerned that consolidation could lead to higher prices and diminished quality of care. This regulatory pressure adds a significant layer of complexity to dealmaking, requiring advisors who can help clients anticipate and mitigate potential roadblocks.

Furthermore, macroeconomic headwinds, including higher interest rates and persistent inflation, have created valuation gaps between buyers and sellers, sometimes slowing the pace of transactions. Successfully closing deals in this environment requires creative structuring and a clear-eyed view of value, reinforcing the need for experienced advisors.

It is precisely this combination of opportunity and complexity that makes a role like Salamon's so critical. His focus will not only be on generating deal flow but also on providing the strategic counsel necessary to navigate these hurdles. MTS is positioning itself as more than just a transaction facilitator, but as a strategic partner that can guide private equity clients through the entire investment lifecycle in a challenging market.

Positioning in a Competitive Arena

MTS Health Partners' strategic enhancement of its sponsor coverage is also a clear move within the competitive chessboard of investment banking. Other leading firms, such as Houlihan Lokey and Cain Brothers, have well-established healthcare groups with strong ties to the private equity community. Houlihan Lokey, for example, has consistently topped league tables for deal volume, advising on hundreds of transactions for financial sponsors annually.

By formalizing its sponsor relationship efforts under Salamon, MTS is ensuring it can compete at the highest level for advisory mandates. The firm has a solid track record, having advised on 130 deals since its inception, including recent transactions that highlight its work with the PE community, such as advising Golden State Medical Supply on its sale to private equity firm Revelar Capital. The appointment of Salamon is designed to accelerate this activity, transforming existing relationships into a more systematic and proactive coverage model.

This strategic hire allows MTS to leverage its reputation as a healthcare-exclusive boutique while adopting the relationship-centric coverage model often seen at larger, more diversified banks. It's a move that aims to combine the best of both worlds: the deep, niche expertise of a specialist with the broad, institutional reach required to serve the world's largest financial sponsors, positioning the firm to capitalize on the enduring and lucrative partnership between private equity and healthcare.